Israeli biomed company Insuline Medical, which develops insulin-delivery technology, has completed a successful financing round, raising NIS 8 Million (approx. $2.19 million). The company has developed technology and medical instruments that increases the effectiveness of insulin injected to people with diabetes.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023

Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023

ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments